Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents
IPCAS
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of this cluster randomized trial is to investigate whether the brief, 1+6 session psychosocial intervention, Interpersonal Counseling (IPC) is more effective than standard professional treatment (ST) in the treatment of mild or moderate depression among 12 to 17-year-old adolescents in services provided by school health care and counseling professionals (school nurses, school psychologists and school social workers). The clients are identified from the pool of adolescents routinely seen in school health care and counseling services. A total of 54 school nurses, social workers, and psychologists from all public secondary schools in the standard education system of City of Espoo, Finland will be trained in IPC in a three-day workshop in two waves. Each school (plus the one primary care level health care unit for adolescents in Espoo) is represented by 1-3 trial IPC counselors. In the first wave the schools are cluster randomized to provide either A) 1+6 sessions of IPC, or B) 1+6 sessions of standard treatment (ST), which consists of psychosocial work as guided by the workers' own standard professional principles and methods. The workers randomized to deliver IPC get the IPC training immediately. In the second wave those who delivered ST in the first wave will be trained in IPC. The data for this trial will be collected from the first wave. The data collection period is one school year plus follow-up of clients after 3 and 6 months. The clients are adolescents who have either self-referred themselves, are referred by other school personnel, or by parents to the services offered in the school due to emotional symptoms in the school year 2016 -2017 in the participating schools. They are screened with the BDI at the initial visit to identify depressive symptoms. A diagnostic interview will be administered to those exceeding a clinical cutoff. Main inclusion criterion is DSM-5 depressive disorder of either mild or moderate severity. Those with current harmful alcohol use, acute suicidal ideation or behavior, severe depression or anxiety disorder, psychotic symptoms or very low global level of functioning are excluded and offered other treatment. The clients will complete self-report questionnaires (BDI) as outcome measures. Their level of depression symptoms will also be assessed with ADRS scale and their level of global psychosocial functioning with the CGAS by the project IPC counselors / ST providers. Moreover, the clients will complete the Young Person's Clinical Outcomes for Routine Evaluation (YP-CORE) as a measure of global symptomatology after each session. A follow-up interview at 3 months and 6 months after treatment termination will be arranged. The K-SADS-PL will be used for diagnostic evaluation, the ADRS and the C-GAS to assess level of depressive symptoms and global functioning, and the adolescent completes both the BDI and YP-CORE as self-reports of symptomatology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 20, 2016
CompletedFirst Posted
Study publicly available on registry
December 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedDecember 22, 2016
December 1, 2016
1.2 years
December 20, 2016
December 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from Baseline in Adolescent Depression Rating Scale after six scheduled treatment sessions
6 weeks
Change from Baseline in Children's Global Assessment of Functioning after six scheduled treatment sessions
6 weeks
Change from Baseline in Beck Depression Inventory after six scheduled treatment sessions
6 weeks
Change from Baseline in Young Person's Clinical Outcomes for Routine Evaluation after six scheduled treatment sessions
one, two, three, four, five, and six weeks
Secondary Outcomes (10)
Change from Baseline in diagnostic status regarding depressive disorder assessed with Kiddie-Sads-Present and Lifetime Version 3 months after treatment termination
3 months after treatment termination
Change from Baseline in diagnostic status regarding depressive disorder assessed with Kiddie-Sads-Present and Lifetime Version 6 months after treatment termination
6 months after treatment termination
Change from Baseline in Adolescent Depression Rating Scale 3 months after treatment termination
3 months after treatment termination
Change from Baseline in Adolescent Depression Rating Scale 6 months after treatment termination
6 months after treatment termination
Change from Baseline in Beck Depression Inventory 3 months after treatment termination
3 months after treatment termination
- +5 more secondary outcomes
Study Arms (2)
IPC
EXPERIMENTALInterpersonal Counseling
ST
ACTIVE COMPARATORStandard treatment
Interventions
Psychosocial treatment 1+6 sessions guided by the professional's standard professional principles and routinely available methods
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of DSM-5 Depressive Disorder (severity mild or moderate)
You may not qualify if:
- current harmful alcohol use
- acute suicidal ideation or behavior
- severe depressive disorder
- severe anxiety disorder
- psychotic symptoms
- very low global level of functioning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital District of Helsinki and Uusimaalead
- Ministry of Social Affairs and Health; Finlandcollaborator
- Finnish Institute for Health and Welfarecollaborator
- City of Espoocollaborator
Study Sites (1)
Department of Adolescent Psychiatry, Helsinki University Central Hospital
Helsinki, P. O.Box 590, FI-00029, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Klaus Y Ranta, M.D., Ph.D.
Hospital District of Helsinki and Uusimaa, Helsinki University Central Hospital
- STUDY DIRECTOR
Mauri Marttunen, M.D., Ph.D.
University of Helsinki, Department of Adolesecent Psychiatry
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Department, Department of Adolescent Psychiatry, Helsinki University Central Hospital
Study Record Dates
First Submitted
December 20, 2016
First Posted
December 22, 2016
Study Start
September 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
December 22, 2016
Record last verified: 2016-12